Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Concetta Crisafulli

Showing results (111-120 of 123) with videos related to

Pageof 13
Sort By:
Journal of Psychiatric Research|March 23, 2017
Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controlsMartina Balestri, Concetta Crisafulli, Luigi Donato, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 25, 2020
<i>ZNF804A</i> Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood DisordersMarco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 30, 2013
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patientsRaffaella Calati, Concetta Crisafulli, Martina Balestri, et al.
Neuroscience Letters|May 24, 2011
COMT and age at onset in mood disorders: a replication and extension studyIsabelle Massat, Neslihan Aygun Kocabas, Concetta Crisafulli, et al.
Neuropsychobiology|January 7, 2012
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depressionAlessandro Serretti, Alberto Chiesa, Concetta Crisafulli, et al.
Journal of Molecular Neuroscience : MN|November 23, 2017
Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological FeaturesMarco Calabrò, Stefano Porcelli, Concetta Crisafulli, et al.
Pharmacogenomics|May 7, 2015
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) studyKristina Probst-Schendzielorz, Catharina Scholl, Olga Efimkina, et al.
Neuroscience Letters|April 11, 2012
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depressionJulien Mendlewicz, Concetta Crisafulli, Raffaella Calati, et al.
Advances in Therapy|May 17, 2017
Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian SamplesMarco Calabrò, Stefano Porcelli, Concetta Crisafulli, et al.
Molecular Biology Reports|January 24, 2020
Correction to: Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer's diseaseMarco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
Pageof 13

Showing results (111-120 of 123) with videos related to

Sort By:
Pageof 13
Journal of Psychiatric Research|March 23, 2017
Nine differentially expressed genes from a post mortem study and their association with suicidal status in a sample of suicide completers, attempters and controlsMartina Balestri, Concetta Crisafulli, Luigi Donato, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 25, 2020
<i>ZNF804A</i> Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood DisordersMarco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|March 30, 2013
Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patientsRaffaella Calati, Concetta Crisafulli, Martina Balestri, et al.
Neuroscience Letters|May 24, 2011
COMT and age at onset in mood disorders: a replication and extension studyIsabelle Massat, Neslihan Aygun Kocabas, Concetta Crisafulli, et al.
Neuropsychobiology|January 7, 2012
Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depressionAlessandro Serretti, Alberto Chiesa, Concetta Crisafulli, et al.
Journal of Molecular Neuroscience : MN|November 23, 2017
Genetic Variants Within Molecular Targets of Antipsychotic Treatment: Effects on Treatment Response, Schizophrenia Risk, and Psychopathological FeaturesMarco Calabrò, Stefano Porcelli, Concetta Crisafulli, et al.
Pharmacogenomics|May 7, 2015
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) studyKristina Probst-Schendzielorz, Catharina Scholl, Olga Efimkina, et al.
Neuroscience Letters|April 11, 2012
Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depressionJulien Mendlewicz, Concetta Crisafulli, Raffaella Calati, et al.
Advances in Therapy|May 17, 2017
Genetic Variants Within Key Nodes of the Cascade of Antipsychotic Mechanisms: Effects on Antipsychotic Response and Schizophrenia Psychopathology in a Naturalistic Treatment Setting in Two Independent Korean and Italian SamplesMarco Calabrò, Stefano Porcelli, Concetta Crisafulli, et al.
Molecular Biology Reports|January 24, 2020
Correction to: Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer's diseaseMarco Calabrò, Laura Mandelli, Concetta Crisafulli, et al.
Pageof 13